Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
America's Car Mart
CRMT
$28.3M
| $822K | ﹤0.01% |
11,372
-10,682
| -48% | -$726K |
|
2652
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.06B
| $821K | ﹤0.01% |
+30,400
| New | +$816K |
|
|
ADAP
2653
DELISTED
Adaptimmune Therapeutics
ADAP
| $819K | ﹤0.01% |
560,973
-5,259
| -0.9% | -$8.52K |
|
2654
Cadre Holdings
CDRE
$1.42B
| $818K | ﹤0.01% |
40,600
+3,000
| +8% | +$77.3K |
|
2655
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
| $816K | ﹤0.01% |
+31,747
| New | +$813K |
|
2656
Heron Therapeutics
HRTX
$93.7M
| $816K | ﹤0.01% |
+326,500
| New | +$1.05M |
|
|
TUYA
2657
Tuya Inc
TUYA
$1.09B
| $816K | ﹤0.01% |
427,000
-185,241
| -30% | -$225K |
|
2658
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.77B
| $812K | ﹤0.01% |
+32,300
| New | +$809K |
|
2659
Instil Bio
TIL
$49.3M
| $809K | ﹤0.01% |
+64,221
| New | +$3.17M |
|
2660
VanEck Agribusiness ETF
MOO
$974M
| $807K | ﹤0.01% |
9,400
-600
| -6% | -$52.7K |
|
|
ACCS
2661
ACCESS Newswire
ACCS
$25.5M
| $805K | ﹤0.01% |
32,138
-3,400
| -10% | -$81.2K |
|
2662
Educational Development Corp
EDUC
$11.8M
| $804K | ﹤0.01% |
254,545
-16,400
| -6% | -$45.1K |
|
2663
Aemetis
AMTX
$117M
| $803K | ﹤0.01% |
202,815
-46,400
| -19% | -$264K |
|
2664
Vanguard Financials ETF
VFH
$13.7B
| $802K | ﹤0.01% |
9,700
+3,000
| +45% | +$248K |
|
2665
Gentherm
THRM
$1.27B
| $801K | ﹤0.01% |
12,264
-29,300
| -70% | -$1.89M |
|
|
RVLP
2666
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $801K | ﹤0.01% |
715,215
-56,792
| -7% | -$90.5K |
|
|
ORC
2667
Orchid Island Capital
ORC
$1.31B
| $795K | ﹤0.01% |
75,760
+18,400
| +32% | +$188K |
|
2668
Bel Fuse Inc Class A
BELFA
$3.4B
| $792K | ﹤0.01% |
24,600
+2,300
| +10% | +$74.7K |
|
|
DHC
2669
Diversified Healthcare Trust
DHC
$2.14B
| $791K | ﹤0.01% |
1,223,683
+377,983
| +45% | +$373K |
|
2670
TELA Bio
TELA
$38.9M
| $790K | ﹤0.01% |
68,732
-1,268
| -2% | -$11.4K |
|
2671
iShares MSCI Switzerland ETF
EWL
$2.23B
| $784K | ﹤0.01% |
+18,700
| New | +$761K |
|
|
SNT
2672
Senstar Technologies
SNT
$42.5M
| $784K | ﹤0.01% |
622,169
-1,186
| -0.2% | -$1.81K |
|
|
SMLR
2673
DELISTED
Semler Scientific
SMLR
| $782K | ﹤0.01% |
23,700
-20,700
| -47% | -$718K |
|
2674
Pacer Lunt Large Cap Alternator ETF
ALTL
$94.4M
| $781K | ﹤0.01% |
+19,300
| New | +$759K |
|
2675
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
| $781K | ﹤0.01% |
33,200
-121,800
| -79% | -$2.87M |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.